Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4177868

O=C(CCCC1CCNCC1)c1ncc(-c2ccco2)o1.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FAAH O00519 17/20 0.54
CES1 P23141 4/20 0.54
DAGLA Q9Y4D2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4180026 0.78 FAAH (0.68) FAAHCES1
SCHEMBL4189345 0.75 FAAH (0.66) FAAHCES1
Hydrochloric Acid SCHEMBL4189029 0.74 FAAH (0.59) FAAHCES1DAGLA
SCHEMBL13875524 0.72 FAAH (0.72) FAAHCES1
SCHEMBL1472048 0.71 FAAH (1.00) FAAHCES1
Hydrochloric Acid SCHEMBL4184818 0.70 FAAH (0.62) FAAHCES1
Hydrochloric Acid SCHEMBL4186982 0.70 FAAH (0.97) FAAH
Trifluoroacetic Acid SCHEMBL7736001 0.69 NPC1 (0.50) FAAH
SCHEMBL3196395 0.66 FAAH (1.00) FAAHCES1
Trifluoroacetic Acid SCHEMBL7723271 0.66 KMT2A (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090111778-A1 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-30 US disclosed
EP-1954137-A4 2-KETO-OXAZOLES AS MODULATORS OF FATTY ACID AMIDE HYDROLASE JANSSEN PHARMACEUTICA NV (BE) 2008-12-17 EP disclosed
EP-1954137-A2 2-KETO-OXAZOLES AS MODULATORS OF FATTY ACID AMIDE HYDROLASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-13 EP disclosed
WO-2007061862-A2 2-KETO-OXAZOLES AS MODULATORS OF FATTY ACID AMIDE HYDROLASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111778-A1 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase FAAH, FAAH2, HCRTR2 FAAH 1/4885CES1 87/4885DAGLA 664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.